Presbia to Complete Second Stage Enrollment in the US FDA Pivotal Study of Presbia Flexivue Microlens
September 03, 2015 at 16:31 PM EDT
Presbia PLC (NASDAQ: LENS), an ophthalmic device company and leader in near vision restoration announced that it has scheduled the ...